IRIS
BELLOCCHI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.925
AS - Asia 2.047
EU - Europa 1.722
SA - Sud America 323
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 16.068
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.839
SG - Singapore 1.005
IT - Italia 427
CN - Cina 347
BR - Brasile 273
RU - Federazione Russa 269
HK - Hong Kong 208
DE - Germania 186
VN - Vietnam 172
SE - Svezia 129
UA - Ucraina 117
IE - Irlanda 112
FR - Francia 111
BD - Bangladesh 97
PL - Polonia 94
FI - Finlandia 82
GB - Regno Unito 78
JP - Giappone 53
CA - Canada 52
KR - Corea 38
IN - India 33
NL - Olanda 32
AR - Argentina 21
MX - Messico 21
ID - Indonesia 20
BE - Belgio 19
AT - Austria 15
CZ - Repubblica Ceca 14
ES - Italia 13
TR - Turchia 12
ZA - Sudafrica 11
UZ - Uzbekistan 10
IQ - Iraq 9
CH - Svizzera 6
CO - Colombia 6
EC - Ecuador 6
MY - Malesia 5
PE - Perù 5
PK - Pakistan 5
AL - Albania 4
CL - Cile 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
PH - Filippine 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
KZ - Kazakistan 3
MN - Mongolia 3
PY - Paraguay 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AU - Australia 2
CM - Camerun 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
HU - Ungheria 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.067
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.879
Wilmington 2.721
Houston 2.449
Singapore 616
Fairfield 414
Ashburn 312
San Jose 291
Chandler 277
Ann Arbor 232
Hong Kong 203
Rome 198
Seattle 181
Beijing 158
Cambridge 136
New York 113
Santa Clara 106
Council Bluffs 105
Dublin 104
Jacksonville 98
Medford 83
The Dalles 80
Los Angeles 71
Creede 69
Kraków 69
Ho Chi Minh City 59
Tokyo 50
Helsinki 46
Buffalo 45
Dearborn 45
Hanoi 44
Moscow 43
Milan 39
Dallas 38
Lawrence 37
Munich 35
São Paulo 28
San Diego 26
Colorado Springs 22
Nuremberg 22
Brussels 19
Orem 19
Warsaw 19
Frankfurt am Main 18
Mülheim 18
Lauterbourg 17
London 17
Brooklyn 16
Montreal 16
Zhengzhou 15
Chicago 14
Jakarta 14
Denver 12
Menlo Park 12
Mountain View 12
Stockholm 12
Florence 11
Redondo Beach 11
Toronto 11
Atlanta 10
Chennai 10
Guangzhou 10
Phoenix 10
Redwood City 10
Brno 9
Columbus 9
Mumbai 9
North Bergen 9
Seoul 9
Boardman 8
Johannesburg 8
Mexico City 8
Amsterdam 7
Boston 7
Falls Church 7
Lappeenranta 7
Magenta 7
Manchester 7
Miami 7
Rio de Janeiro 7
Tashkent 7
Brasília 6
Da Nang 6
Naples 6
Palo Alto 6
Paris 6
San Francisco 6
Vienna 6
Bologna 5
Cagliari 5
Cedarhurst 5
Detroit 5
Dong Ket 5
Las Vegas 5
Norwalk 5
Olomouc 5
Shanghai 5
University Park 5
Verona 5
Zurich 5
Belo Horizonte 4
Totale 13.115
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 534
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso 507
Virologic correlates of adherence to antiretroviral medications and therapeutic failure 506
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases 500
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 489
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 487
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 486
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 476
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 476
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors 474
Population variation analysis at nine loci containing expressed trinucleotide repeats 472
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 468
Incomplete APOBEC3G/F neutralization by HIV-1 Vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage 448
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme 447
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy 444
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 442
Dynamics of NRTI resistance mutations during therapy interruption 440
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy 429
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir 425
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 410
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients with Acute Hepatitis B 409
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors 408
Temporal change in the use of genotypic resistance testing over the years 1999--2003 408
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 400
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 384
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 307
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 259
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 232
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 205
Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation 162
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 155
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 152
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 151
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 139
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study 133
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 130
Characterization of HBV and HCV minority quasispecies by ultra-deep pyrosequencing analysis: impact on pathogenicity and response to antiviral drugs 116
HHV-8 genetic diversification and its impact on severe clinical presentation of associated diseases 113
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 109
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 107
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 103
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 102
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 101
First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus 101
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 91
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 90
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 89
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? 88
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 84
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 81
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors 75
Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients. 74
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era 74
Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients 74
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 69
Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort 67
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units 65
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure 63
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 58
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy 54
Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure 52
Long-term evaluation of the effect of genotype-based antiretroviral therapy upon virological, immunological, and clinical parameters 51
Using a database of genotype resistance tests to describe characteristics related to detection of the multinucleoside resistance-associated Q151M mutation. 51
Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase 43
Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors 42
Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen 41
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation 41
Development of a Next-Generation Sequencing Protocol for Assessing Lenacapavir Resistance in HIV-1 Capsid 16
null 3
Totale 16.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.622
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022570 42 45 33 36 20 35 26 25 123 45 24 116
2022/2023895 77 66 52 88 47 131 38 224 51 69 41 11
2023/2024323 55 5 27 16 30 85 7 11 12 18 3 54
2024/20251.647 75 357 177 144 43 80 170 76 164 131 100 130
2025/20263.019 309 121 277 311 264 110 368 394 332 214 147 172
2026/202718 18 0 0 0 0 0 0 0 0 0 0 0
Totale 16.359